Fingerprint
Dive into the research topics of 'Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically